Advertisement

Topics

PR $MGNX $ZLAB https://globenewswire.com/news-release/2018/11/29/1658855/0/en/MacroGenics-and-Zai-Lab-Announce-Exclusive-Collaboration-and-License-Agreement-to-Develop-and-Commercialize-Margetuximab-MGD013-and-TRIDENT-Molecule-in-Greater-China.html …

07:33 EST 29 Nov 2018 | Odi Bruckman

PR https://globenewswire.com/news-release/2018/11/29/1658855/0/en/MacroGenics-and-Zai-Lab-Announce-Exclusive-Collaboration-and-License-Agreement-to-Develop-and-Commercialize-Margetuximab-MGD013-and-TRIDENT-Molecule-in-Greater-China.html …

Original Article: PR $MGNX $ZLAB https://globenewswire.com/news-release/2018/11/29/1658855/0/en/MacroGenics-and-Zai-Lab-Announce-Exclusive-Collaboration-and-License-Agreement-to-Develop-and-Commercialize-Margetuximab-MGD013-and-TRIDENT-Molecule-in-Greater-China.html …

NEXT ARTICLE

More From BioPortfolio on "PR $MGNX $ZLAB https://globenewswire.com/news-release/2018/11/29/1658855/0/en/MacroGenics-and-Zai-Lab-Announce-Exclusive-Collaboration-and-License-Agreement-to-Develop-and-Commercialize-Margetuximab-MGD013-and-TRIDENT-Molecule-in-Greater-China.html …"

Advertisement
Quick Search
Advertisement
Advertisement